Goodrx Holdings Inc (GDRX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.47x

Goodrx Holdings Inc (GDRX) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting $36.00 Million (capex $18.00 Million plus investments $-18.00 Million) from operating cash flow of $76.02 Million. Explore Goodrx Holdings Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.47x
(Capex + Investments) / Operating CF

Total Reinvested

$36.00 Million
Capex + Investments

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Goodrx Holdings Inc Cash Flow Reinvestment Rate (2018–2024)

Historical reinvestment intensity for Goodrx Holdings Inc across 7 annual periods. Also explore how large is Goodrx Holdings Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Goodrx Holdings Inc (2018–2024)

Year-by-year capital reinvestment analysis for Goodrx Holdings Inc. For live market cap and broader valuation context, see market cap of Goodrx Holdings Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.77x $140.69 Million $183.89 Million $70.35 Million ▲ +8.7%
2023 0.70x $97.37 Million $138.29 Million $55.77 Million ▼ -61.1%
2022 1.81x $265.71 Million $146.78 Million $55.21 Million ▲ +51.8%
2021 1.19x $213.19 Million $178.78 Million $34.46 Million ▲ +22.9%
2020 0.97x $127.44 Million $131.34 Million $35.82 Million ▲ +88.8%
2019 0.51x $42.80 Million $83.29 Million $5.75 Million ▲ +236.3%
2018 0.15x $6.92 Million $45.25 Million $3.46 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow